<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00161850</url>
  </required_header>
  <id_info>
    <org_study_id>206</org_study_id>
    <nct_id>NCT00161850</nct_id>
  </id_info>
  <brief_title>FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years</brief_title>
  <official_title>Follow-up Study to Investigate the Safety and Immunogenicity of a Third Vaccination With Three Different Antigen Concentrations of FSME IMMUN NEW in Children Aged 1 to 6 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the safety and immunogenicity of the third
      vaccination with one of three different concentrations of a TBE vaccine in all subjects who
      completed two vaccinations in one of the three treatment groups of Baxter study 199 (a
      dose-finding study to investigate the safety and immunogenicity of two vaccinations with FSME
      IMMUN NEW in healthy subjects aged 1 to 6 years).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2002</start_date>
  <completion_date>August 2002</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>615</enrollment>
  <condition>Encephalitis, Tick-borne</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All volunteers who participated in Baxter study 199 and received two vaccinations will be
        invited to participate. Male and female children will be eligible for participation in this
        study if:

          -  They received two vaccinations with one of the three different dosages of FSME IMMUN
             NEW during the course of Baxter study 199

          -  Written informed consent from the legal guardian is available.

        Exclusion Criteria:

        There are no specific exclusion criteria for this study entry. However volunteers will be
        assessed for eligibility to receive a third vaccination.

        Volunteers will be excluded from vaccination and consecutive visits in this study if they:

          -  Are not clinically healthy, (i. e. the physician would have reservations vaccinating
             with FSME IMMUN NEW outside the scope of a clinical trial)

          -  Have already been administered a third TBE vaccination elsewhere after the two
             vaccinations in Baxter study 199

          -  Have had an allergic reaction to one of the components of the vaccine since the last
             vaccination in Baxter study 199

          -  Suffer from a disease (e.g. autoimmune disease) or are undergoing a form of treatment
             (e.g. systemic corticosteroids, chemotherapeutics) that can be expected to influence
             immunological functions

          -  Have received banked human blood or immunoglobulins within one month of study entry

          -  Are known to be HIV positive (a special HIV test is not required for the purpose of
             the study) since the last visit of Baxter study 199

          -  Have had a vaccination against yellow fever and / or Japanese B-encephalitis since the
             last visit in Baxter study 199

          -  Had received an investigational new drug within 6 weeks prior to study start
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Baxter BioScience Investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baxter Healthcare Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grieskirchner Strasse 17</name>
      <address>
        <city>Wels</city>
        <zip>A-4600</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neuschwanstein Strasse 5</name>
      <address>
        <city>Augsburg</city>
        <zip>D-86163</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marktplatz 33</name>
      <address>
        <city>Bad Saulgau</city>
        <zip>D-88348</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hauptstrasse 9</name>
      <address>
        <city>Bietigheim-Bissingen</city>
        <zip>D-74321</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Salzgasse 11</name>
      <address>
        <city>Calw</city>
        <zip>D-75365</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mohrenstrasse 8</name>
      <address>
        <city>Coburg</city>
        <zip>D-96450</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bahnhofstrasse 1</name>
      <address>
        <city>Elzach</city>
        <zip>D-79215</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheinstrasse 1a</name>
      <address>
        <city>Ettenheim</city>
        <zip>D-77955</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ehlerstrasse 17</name>
      <address>
        <city>Friedrichshafen</city>
        <zip>D-88046</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peter-Seifert Strasse 5</name>
      <address>
        <city>Gersfeld</city>
        <zip>D-36129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Solothumer Strasse 2</name>
      <address>
        <city>Heilbronn</city>
        <zip>D-74072</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hauptstrasse 240</name>
      <address>
        <city>Kehl</city>
        <zip>D-77694</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schwarzwald Strasse 20</name>
      <address>
        <city>Kirchzarten</city>
        <zip>D-79199</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Altoettinger Strasse 3</name>
      <address>
        <city>Landsberg</city>
        <zip>D-86899</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rastatter Strasse 7</name>
      <address>
        <city>Mannheim-Secken</city>
        <zip>68239</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wilhelmstrasse 25</name>
      <address>
        <city>Metzingen</city>
        <zip>D-72555</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dohmbuehler Strasse 8</name>
      <address>
        <city>Nuernberg</city>
        <zip>D-90449</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glogauer Strasse 15</name>
      <address>
        <city>Nuernberg</city>
        <zip>D-90473</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tuchbergstrasse 2</name>
      <address>
        <city>Oberndorf/Neckar</city>
        <zip>D-78727</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wilhelmstrasse 7</name>
      <address>
        <city>Offenburg</city>
        <zip>D-77654</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asternweg 11a</name>
      <address>
        <city>Offenburg</city>
        <zip>D-77656</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bergstrasse 27</name>
      <address>
        <city>Rottweil</city>
        <zip>D-78628</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berneckstrasse 19</name>
      <address>
        <city>Schramberg</city>
        <zip>D-78713</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hauptstrasse 11</name>
      <address>
        <city>Tegernsee</city>
        <zip>D-83681</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Broner Platz 6</name>
      <address>
        <city>Weingarten</city>
        <zip>D-88250</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2005</study_first_posted>
  <last_update_submitted>May 20, 2015</last_update_submitted>
  <last_update_submitted_qc>May 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Encephalitis</mesh_term>
    <mesh_term>Encephalitis, Tick-Borne</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

